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Abstract: Carbon nanotubes (CNTs) are emerging versatile tools in nanomedicine   applications, 
particularly in the field of cancer targeting. Due to diverse surface chemistry and unique thermal 
properties, CNTs can act as strong optical absorbers in near infrared light where biological 
systems prove to be highly transparent. The process of laser-mediated ablation of cancer cells 
marked with biofunctionalized CNTs is frequently termed “nanophotothermolysis.” This paper 
illustrates the potential of engineered CNTs as laser-activated photothermal agents for the 
  selective nanophotothermolysis of cancer cells.
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Introduction
During the past decade advances in fuctionalization chemistry have been one of the 
driving forces in the development of new classes of novel nanomaterials for applica-
tions in biology and medicine.1–8
Carbon nanotubes (CNTs), with their unique physical and chemical properties, 
hold great promise for drug delivery and cancer therapy.9 The research mechanisms 
of selective tumor targeting with biofunctionalized CNTs are currently being intensely 
explored due to their impressive ability to convert near-infrared (NIR) laser radiation 
into heat. This intrinsic property opens new avenues for the development of novel 
immunoconjugates for cancer phototherapy with high performance and efficacy in the 
selective thermal ablation of malignant cells.10,11 This method is based on the intraci-
toplasmatic internalization and clustering of CNTs and their highly optical absorbtion 
under NIR laser radiation where the biological systems have low absorption and high 
transparency.12 The optoelectronic transitions in the graphitic structures of the CNTs 
clusters generate thermal energy13 that rapidly diffuses into the various cell compart-
ments, where the CNTs are present, with consequent cell necrosis.
The development of targeted therapy represents an exciting and new approach to 
cancer treatment.14 Conceptually, a targeted drug represents a responsive molecule 
attached to a delivery carrier with affinity for specific surface receptor proteins located 
in cell membranes.15–17 Being endowed with target specificity, the carrier is able to 
concentrate only in the desired biological area. The use of these biological carriers 
for the development of specific and sensitive site-targeted bionanosystems makes 
possible the selective internalization of molecules with photothermal properties in 
cancer cells. This internalization process is not possible under normal conditions.18,19 International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1676
Iancu and Mocan
Therefore, such bioconjugation holds tremendous   potential 
for future cancer treatment. However, 100% selective inter-
nalization of nanobioconjugates in the cancer cells remains 
problematic.20,21 While progress has been made in biofunc-
tionalization of CNTs using various biological molecules 
such as polyethylene glycol (PEG), DNA, antibodies, folates, 
cytostatic drugs, and growth factors,22–27 there is a signifi-
cant lack of knowledge on how to obtain selectivity these 
compounds for a single type of cancer cell. This lack is due 
to the simultaneous presence of the receptors used for the 
specific binding of the targeting molecules to the membranes 
of the noncancerous cells, although in smaller amount than 
the cancer cells.28–31
Photothermal ablation of malign cells containing 
intracytoplasmatic CNTs may be used in two main modes: 
pulsed and continuous. The first mode produces localized 
(a few micrometers) necrosis of individual cancer cells by 
thermal micro- and nanobubbles around overheated nano-
particles without harmful effects on the surrounding cells. 
The pulsed mode produces in vivo killing of single circulat-
ing tumor cells using just one-nanosecond laser pulses. The 
second mode lasts longer (several minutes of exposure) and 
produces cell damage through nuclear fragmentation and 
organelles   disintegration. It is recommended for the treatment 
of primary tumors measuring a few millimeters.12,32
In this review, we first summarize the current progress 
in the use of CNTs for the in vitro selective photothermal 
abation of cancer cells studies as well as pioneering efforts 
towards in vivo and ex vivo therapies.
Intracellular internalization of 
CNTs
Various mechanisms for the internalization pathway of 
single-walled CNTs (SWCNTs) inside living cells have 
been proposed. Pantarotto et al33 suggested that insertion 
and diffusion of nanotubes across cell membranes is an 
energy-independent nonendocytotic process. In contrast, 
other reports showed that transmembranar transport of 
SWCNTs conjugates with proteins and DNA is through 
the clathrin-  dependent endocytosis pathway.34 However 
these controversies on the internalization mechanism were 
explained by several differences in both the nanotube mate-
rial and experimental procedures that were used in these two 
studies.35 It has been stated that a proficient method needed to 
minimize toxic effects and also to increase the level of thera-
peutic response for CNTs, is represented by their conjugation 
to a carrier molecule.25,35–42 For instance, various strategies 
for the fabrication of nanomoieties to target folate receptors 
on the cancer cell membrane have been proposed.12 Folate 
receptors are overexpressed in cancer and their targeting 
allows CNTs to facilitate cellular internalization of folate-
containing species by receptor-mediated endocytosis43 which 
is more selective than CNTs alone that enter cells through 
phagocytosis or endocytosis and through passive diffusion.
In vitro nanophototermolysis of 
tumors mediated by CNTs
The first in vitro published observation of the potential of 
CNTs with very high optical absorbance in the NIR regime 
(where biological systems are transparent) such as photo-
thermal vectors12 stimulated significant interest and research, 
leading to rapid development in the field (Figure 1).
In vitro nanophotothermolysis of  
cervical cancer
In one study, HeLa cells with internalized SWCNTs conju-
gated to single strand DNA were irradiated under a 1.4 W/cm2 
power laser.12 Notably, these authors reported extensive 
cell death after 2 minutes of radiation suggested by cell 
morphology changes, loss of attachment, and aggregation of 
organelles debris. Raman spectroscopy and scanning electron 
microscopy identified SWCNTs mixed with cell debris in 
the black aggregates and confirmed that local heating was 
the most likely origin of cell death. In contrast, cells with-
out exposure to SWCNTs survived continuous 3.5 W/cm2, 
808 nm laser radiation for 5 minutes.
In a study conducted by Biris et al, advanced IR thermog-
raphy was used for the remote measuring the laser-induced 
photothermal effects of HeLa cells exposed to the 1064-nm 
laser irradiation before and after the cells were incubated with 
CNTs for 48 hours.44 IR thermal analysis studies performed 
before the cells were incubated with CNTs indicated that no 
notable temperature variation (,1.5°C) was induced by the 
laser radiation. When HeLa cells were incubated with the 
CNTs for 48 hours, the authors showed that intracellular heat 
dramatically increased after laser irradiation.
In vitro nanophotothermolysis of 
prostate cancer
In a study conducted by Fisher et al, human prostate cancer 
(PC3) cells were irradiated with a 1064 nm laser with an 
irradiance of 15.3 W/cm2 for two heating durations (1.5 
and 5 minutes) alone or in combination with internalized 
multiwalled CNTs (MWCNTs).45 Cytotoxicity tests and 
heat shock proteins expression following laser heating were 
used to determine the efficacy of laser treatment alone or in International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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combination with MWCNTs. The authors found that cell 
viability dramatically decreased after laser irradiation. When 
cells were incubated longer, a greater number of MWCNTs 
were observed at transmission electron micrograph (TEM) 
analysis in cellular vacuoles and nuclei.
In vitro nanophotothermolysis of brain 
cancer
The photothermal anticancer activity of NIR-excited gra-
phene nanoparticles and CNTs were compared for induc-
tion of photothermal necrosis of U251 human glioma cells 
in vitro.46 In this approach, the glioma cells were treated with 
carbon nanoparticles (2.5–10 µg/mL) and further exposed to 
NIR irradiation (808 nm, 2 W/cm2) for different periods of 
time (30–300 seconds). As result, both carbon nanoparticles 
displayed a dose-dependent and time-dependent totoxicity 
on U251 cells. Notably, the graphene nanoparticles were 
several-fold more efficient in photothermal killing of glioma 
cells than CNTs bound to DNA at the same concentrations. 
The patterns of graphene-mediated photothermal necrosis 
proved to involve oxidative stress and mitochondrial mem-
brane depolarization with consequent caspase activation/
DNA fragmentation.
Glioblastoma GBM-CD133 (+) and GBM-CD133 (−) cells 
were incubated with SWCNTs conjugated with CD133 mono-
clonal antibody (anti-CD133) and then irradiated with NIR 
laser light.47 Results showed that GBM-CD133 (+) cells were 
selectively targeted and destroyed, while GBM-CD133 (−) cells 
remained viable. In addition, the authors proved that in vitro 
tumorigenic and self-renewal capability of GBM-CD133 (+) 
treated with localized hyperthermia was significantly reduced. 
To that end, the GBM-CD133 (+) cells pretreated with anti-
CD133-SWCNTs and irradiated by NIR laser 2 days after 
xenotransplantation in nude mice did not exhibit sustainability 
of cancer stem cell features for tumor growth. The thermal 
energy produced by NIR-activated CD-SWCNTs was sufficient 
to destroy GBMD133+ cells xenotransplanted in mice and 
consequently to stop tumor growth.
In order to specifically target disialoganglioside (GD2) 
receptors on the surface of neuroblastoma stNB-V1 cells, 
GD2 monoclonal antibody (anti-GD2) was conjugated to 
CNTs.41 After the treatment of neuroblastoma cells with 
anti-GD2 conjugated CNTs for 6 hours, the cells were further 
irradiated with an 808 nm NIR laser with intensity increas-
ing from 0.6 to 6 W/cm2 for 10 minutes which was then 
maintained at 6 W/cm2 for an additional 5 minutes. Post-NIR 
laser exposure and after being examined by calcein-AM dye, 
stNB-V1 cells were all foud to be necrotic, while non-GD2 
expressing PC12 cells (control) remained viable.
In vitro nanophotothermolysis of liver 
cancer
Recently, considering the important role of human serum 
albumin (HSA) in tumor metabolism48–51 (since it is used for 
the synthesis of various cellular substrates), we have bound 
human albumin to MWCNTs for the selective targeting of 
liver cancer cells.52 Most data show that caveolae-mediated 
endocytosis in cells is activated by the binding of albumin to 
a specific endothelin receptor gp60, a receptor located in the 
caveolae.53 In this work, using confocal (Figure 2) and TEM, 
we showed that the mechanism of HSA-MWCNTs uptake in 
HepG2 cells occurs through caveolae-dependent endocytosis 
initiated by the selective binding of HSA-MWCNTs to gp60 
receptor called albondin. To accomplish this, we treated the 
cells with 5 mg/L HSA-MWCNTs marked with fluorescein iso-
thiocyanate (FITC) for 1 hour followed by incorporation of cy3-
anti-gp60 antibody for 30 minutes at 37°C. Further, we showed 
that HepG2 cells internalized with albumin-bound MWCNTs 
(fluorescently marked with FITC) were distributed into a green 
punctate structure inside the cells (Figure 2A, second panel). 
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Figure I Schematic illustration of in vitro selective photothermal ablation of cancer by laser activated intracellulary biofunctionalized carbon nanotubes.
Abbreviations: Ab, antibody; CNT, carbon nanotube; NIR, near-infrared.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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In Figure 2 A, fourth panel, nearly complete co-localization of 
green fluorescence and red fluorescence was evident as yellow 
in the merged image. This finding demonstrates that albumin 
bound to MWCNTs was incorporated into vesicles contain-
ing gp60 as a membrane protein, validating HSA-MWCNTs 
specificity for gp60 receptors. In contrast, as seen in Figure 2B, 
no significant co-localization in the normal cells was observed 
for cy3-gp60 antibody and HSA-FITC-MWCNTs incubated 
under the same circumstances. Therefore, based on these data, 
we showed that HSA-MWCNTs can act as specific and sensi-
tive site-targeted nanosystems against gp60 receptor located 
on the liver cancer cell’s membrane (Figure 3).
In the next step, HepG2 cells and hepatocytes (control) 
were treated with HSA-MWCNTs at various concentrations 
and at various incubation times, and further irradiated using a 
2 W, 808 nm laser beam. The post-irradiation apoptotic rate 
of HepG2 cells treated with HSA-MWCNTs was 88.24% 
(for 50 mg/L) at 60 seconds, while at 30 minutes the rate 
increased to 92.34% (50 mg/L). Significantly lower necrosis 
rates were obtained when human hepatocytes were treated 
with HSA-MWCNTs in a similar manner.
In vitro nanophotothermolysis of 
Burkitt’s lymphoma
SWCNTs bound to CD22 monoclonal antibody were shown 
to retain their photonic properties and selectively internalized 
anti-CD22+ mab human Burkitt’s lymphoma in vitro.54 The 
cells were incubated with CNTs coupled to the anti-CD22 
monoclonal antibodies (mAb) (RFB4) and further exposed 
to an 808 nm laser (5 W/cm2) for 7 minutes and pulsed for 
the next 12 hours with [3H] thymidine to assess cell viability. 
In another paper, the same authors reported a significantly 
increased necrosis rate in RFB4-CNT-treated Daudi cells 
compared with unconjugated CNTs. The viability of the 
RFB4-CNT-treated Daudi cells was significantly reduced 
after exposure to NIR light (P , 0.0001).55
In vitro nanophotothermolysis of breast 
cancer
BT474 breast cancer cells were treated with SWCNTs fab-
ricated using a methane-based chemical-vapor-deposition 
method at various concentrations and further irradiated 
Hep G2
Hep G2
CRL-4020
Figure 2 HSA-MwCNTs in vitro endocytosis mechanism in human liver cancer cells. (A) Co-localization of the Cy-gp60 antibody and FITC-HSA-MwCNTs in HepG2 
cells. (B) co-localization of the Cy-gp60 antibody and FITC-HSA-MwCNTs in hepatocyte epithelial cells. (C) co-localization of the caveolin-1-Cy antibody and FITC-HSA-
MwCNTs in HepG2 cells. Results are representative of three experiments. 
Notes: Scale bar: 20 µm in all panels. Reprinted with permission from Iancu C, Mocan L, Bele C, et al. enhanced laser thermal ablation for the in vitro treatment of liver cancer 
by specific delivery of multiwalled carbon nanotubes functionalized with human serum albumin. Int J Nanomedicine. 2011;6:129-141.52 Copyright © 2011 Dove Medical Press.
Abbreviations: Ab, antibody; DAPI, 4’-6-diamidino-2-phenylindole; FITC, fluorescein isothiocyanate; HSA, human serum albumin; MWCNTs, multiwalled carbon nanotubes.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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(800 nm and 200 mW/cm2), killing all the cells in less than 
60 seconds.56 The authors showed the existence of bubbles 
around the dead cells, further indicating that the boiling 
was due to SWCNTs explosions. These “nanobombs” were 
produced as a result of heat confinement in bundles of 
SWCNTs and the presence of adsorbed water molecules. The 
local heat rapidly caused extreme pressures in between the 
bundles of SWCNTs, resulting in further   “nanoexplosions.” 
These explosions were adjusted by changes in the intensity 
of NIR.
Another group covalently attached a monoclonal anti-
body that is specific for Her2, a clinically important marker 
on breast cancer cells, on the surface of CNTs.30 These 
conjugates were further tested for their ability to induce 
breast cancer cells necrosis following exposure to NIR light 
(4 W/cm2) for 9 minutes. Cell death was detected 24 hours 
later by staining the trypsin-detached cells with FITC-labeled 
HER81, an anti-Her2 mAb. Subsequently, the distribution of 
dead cells among the two cell populations was evaluated by 
flow cytometry according to Her2 positivity and   providone 
- HSA-MWCNTs
Caveosome
Early
endosome
Gp60-R
Dissociation
of HSA-MWCNTs
MWCNTs
clusters
Matured
endosome
Caveolin-
Figure 3 The proposed mechanism for albumin receptor mediated internalization of HSA-MwCNT inside HepG2 cells (schematic drawing). MwCNT internalization 
involves the selective uptake of HSA-MwCNT with the aid of albumin (GP60) receptors. This usually begins with the formation of caveolar invaginations on the plasma 
membrane surface. These pits are called caveosomes. The vesicles then transform into early endosomes. Matured (late) endosomes receive internalized material en route 
to lysosomes, usually from early endosomes in the endocytic pathway and most of the associated receptors circulate back to the cell membrane. Late endosomes mediate a 
final set of sorting events prior to delivery of material to lysosomes. Lysosomes are the last compartment of the endocytic pathway. The MWCNTs are released inside the 
cytoplasm forming clusters and HSA is digested by lysosomes.
Abbreviations: Ab, antibody; HSA, human serum albumin; MwCNT, multiwalled carbon nanotube.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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iodine staining. The authors found that under the laser 
exposure noted above, about 38.8% of Her2+ target cells 
were killed compared with less than 10% of the nontargeted 
Her2− cells. The same report showed that anti-Her2–CNTs 
can be actively endocytosed by breast cancer cells.
Various strategies for the fabrication of CNTs bioconju-
gates with a role in photothermal ablation of breast cancer 
cells have been proposed. Xiao et al have tested a HER2 
IgY-SWCNTs complex for both detection and selective 
destruction of malign cells in an in vitro model consisting 
of HER2-expressing SK-BR-3 cells and HER2-negative 
MCF-7 cells.40,57 In fact, NIR irradiation with a 808 nm laser 
at 5 W/cm2 for 2 minutes of SK-BR-3 cells treated with the 
HER2 IgY-SWCNTs complex showed extensive cellular 
thermal necrosis (95% of the cells were necrotic); in contrast, 
the viability of SK-BR-3 cells treated with SWCNTs alone 
or untreated and of MCF-7 cells treated with the HER2 IgY-
SWCNTs complex was not affected (the cells were 100% 
viable). Based on the temperature measurements of the IgY-
SWCNTs complex solution at the nanotube concentration 
of 4 mg/L that exhibited an increase of ∼14°C in the bulk 
solution, the authors stated that the temperature increase in 
the surrounding environment would not cause damage to 
normal cells that do not bind to the SWCNTs-containing 
complex in the short time period (2 minutes).
In vivo photothermal ablation of 
tumors mediated by CNTs
The “holy grail” in CNTs-mediated targeted cancer photo-
therapy36 is to deliver high doses of active bionanomolecules 
to tumor sites for maximum treatment efficacy while mini-
mizing side effects to normal organs58 (Figure 4).
In vivo nanophotothermolysis of 
squamous cell carcinoma
In a study conducted by Huang et al SCCVII tumors in C3H/HeN 
mice were exposed to 785 nm laser after   intratumoral injection 
of SWCNTs with different wavelengths and SWCNTs dose 
combinations.59 Following the treatment, the temperatures of 
the tumor tissue during laser irradiation were monitored. Tumor 
responses (tumor volume monitoring and survival parameters) 
were evaluated daily after treatment up to day 45 to assess the 
efficiency of the treatment. Surprisingly, the authors found that 
in mice treated with 1 mg/mL SWCNTs and further irradiated 
with 200 mW/cm2, the tumors became clinically silent (impal-
pable) 1 day after treatment. In stark contrast, tumors in the 
negative control group, SWCNTs-only group, and laser-only 
groups continued to grow. After the treatment, the authors found 
that at 45 days, five mice were still alive in the 200 mW/cm2 + 
1 mg/mL group, three mice in the 200 mW/cm2 + 0.5 mg/mL 
group, two mice in the 200 mW/cm2 + 0.1 mg/mL group and 
one mouse in the 100 mW/cm2 + 0.5 mg/ml group (initially 
there were eight mice in each group) (log rank test among 
the groups: ,0.005) The authors also reported a temperature 
increase on average, by 18.5°C in 200 mW/cm2 + 1 mg/mL 
group, 14.2°C in 200 mW/cm2 + 0.5 mg/mL group, 11.7°C 
in 200 mW/cm2 + 0.1 mg/mL group, around 10°C in all the 
three 100 mW/cm2 + drug groups, and 6.1 and 7.9°C in the 
100 and 200 mW/cm2 laser-only groups, respectively, at the 
end of   treatment. The authors concluded that squamous cell 
carcinomas can be safely eradicated by photothermal therapy 
using intratumoral injection of SWCNTs and 785 nm NIR 
irradiation at a moderate light irradiance (200 mW/cm2 and 
120 J/cm2).
In vivo nanophotothermolysis of  
prostate cancer
Ghosh et al showed that DNA encasement of MWCNTs 
increases local heat production (which is generated with a 
linear dependence on irradiation time and laser power) fol-
lowing NIR irradiation and that these DNA-encased nanocon-
jugates can be used to safely eradicate a tumor mass in vivo.60 
The authors found that DNA encasement resulted in a three-
fold reduction in the concentration of MWCNTs required to 
Administration Binding Internalization NIR necrosis
Figure 4 Schematic illustration of the in vivo Ab-CNTs mediated ablation of malign tumors.
Note: Reprinted with permission from Mocan L, Tabaran F, Mocan T, et al. Selective ex-vivo photothermal ablation of human pancreatic cancer with albumin functionalized 
multiwalled carbon nanotubes. Int J Nanomedicine. 2011;6(1):915–928.19 Copyright © 2011 Dove Medical Press.
Abbreviations: Ab, antibody; CNTs, carbon nanotubes.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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increase temperature of bulk solution by 10°C. After intra-
tumoral administration of MWCNTs (500 mg/L) combined 
with external laser irradiation at 1064 nm, 2.5 W/cm2, the 
authors reported complete necrosis of prostate cancer PC3 
xenograft tumors. In contrast, tumors that received only 
MWCNTs injection or laser irradiation showed growth rates 
indistinguishable from that of untreated controls. The healthy 
surrounding tissue was not affected. The presented results 
showed that DNA-encased MWCNTs are more efficient at 
converting NIR irradiation into heat compared with nonen-
cased MWCNTs therefore may be safely used for the in vivo 
selective thermal ablation of malignant tissue.
In vivo nanophotothermolysis of  
kidney cancer
MWCNTs response to NIR was used for the thermal destruc-
tion of kidney cancer in vitro and in vivo.61 In this research, 
MWCNTs were efficient in thermal ablation of tumors with 
low laser powers (3 W/cm2) and very short treatment times 
(30-seconds). The tumor involution following the treatment 
depended on the concentration of MWCNTs administered. 
At a dose of 100 µg of MWCNTs, complete tumor regression 
without recurrence for 12 weeks after the treatment (a single 
30-second treatment with 3 W/cm2 NIR) was observed in 80% 
of the mice. In contrast, tumor regression was not seen in 
untreated mice, mice treated with MWCNTs alone, or mice 
treated with laser-generated NIR alone. The authors reported 
an increase in the temperature to 76°C in MWCNTs-treated 
tumor tissue after laser irradiation while the peak temperature 
measured in laser-irradiated tumors was 46°C in the absence 
of MWCNTs.
In vivo nanophotothermolysis of liver 
cancer
In one study, a group of rabbits, all implanted with the 
same form of hepatic VX2 liver cancer, was used as test 
subjects.62 Kentera functionalized SWCNTs were further 
injected directly into their tumors and then immediately 
placed inside a radiofrequency field (600 W for 2 minutes) 
and positioned so that the tumor would get maximum field 
energy. The experiment resulted in the malignant tumor cells 
being completely destroyed in the experimental group with 
no noted adverse side effects in the test subjects.
Ex vivo photothermal ablation of 
tumors mediated by CNTs
Several authors have evaluated histological samples with 
and without photothermal-mediated nanoparticles treatment 
using photothermal scanning cytometry for color-coded 
imaging, spectral identification, and quantitative detection 
of individual nanoparticles. The obtained data highlighted 
the promise of photothermal cytometry in the analysis of 
low-absorption samples and mapping of the distribution of 
various individual nanoparticles that would be impossible 
with existing assays.63 One group investigated the optical 
and thermal response to laser radiation of representative tis-
sue biopsies containing MWCNTs. The rate of temperature 
increase and peak temperature for tissue pieces containing 
MWCNTs was much greater compared with tissue biopsies 
without MWCNTs at all measurement locations.64
ex vivo nanophotothermolysis of 
pancreatic cancer
Considering the important role of albumin in tumor 
metabolism,63 we have used human albumin bound to 
MWCNTs for the ex vivo selective targeting of pancreatic 
cancer. Since ethical limitations made the selectivity and 
therapeutic potential of these nanocompounds in patients 
impossible to test, we have designed an original model 
of living pancreatic cancer harvested and preserved in a 
similar manner as for pancreatic transplantation. We used 
ex vivo-perfused pancreatic specimens that had been surgi-
cally removed from patients with ductal adenocarcinoma 
(Figure 5). On this model, the intra-arterial administration 
of albumin conjugated with MWCNTs (200 mg/L) specifi-
cally induced the release of this nanobioconjugate inside the 
malign tissue via the “capillary bed.”
We showed that extensive and selective tumoral necrosis 
was obtained when the living pancreas underwent laser irra-
diation (30 minutes, 808 nm, 5 W/cm2) after the administra-
tion of HSA-MWCNTs via the greater pancreatic artery. In 
this experiment, all the existing situations met in surgical 
practice were replicated.
Biodistribution and 
pharmacokinetics of CNTs
Despite their unique features, the toxicity and biological 
interactions of CNTs represent a major concern, with several 
authors pointing to their similarity to asbestos fibers.65,66 
Many factors attributed to CNTs such as biofunctionalization, 
length, concentration, duration of exposure, and methods of 
dispersion have been associated with CNTs toxicity in both 
in vitro and in vivo studies.67
To date, few in vitro experiments assert that oxidative 
stress from CNTs is a major result of toxicity. However, the 
number studies suggesting that CNTs are nontoxic in vivo International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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outnumbers those proposing otherwise. It has been stated 
that toxicity of CNTs is negligible in mice with chronic 
exposure to CNTs.68 Following administration of PEGylated 
SWCNTs, changes in neutrophil count were lower than 
counts from those mice treated with PEGylated oxidized 
SWCNTs. This fact suggests that varying functionalization 
can modify toxicity.69
Following intravenous administration in mice, CNTs are 
excreted in the urine. Moreover, CNTs deposits were found 
in the liver, spleen, and lungs.10 Other studies indicate that 
CNTs deposits are mostly found in the excretory systems 
like the bladder, kidneys, and large bowel.70,71
Future perspectives
From a clinical perspective, the CNTs-mediated photother-
mal ablation of cancers implies ultrasound identification of 
the tumor and its vascular supply, intra-arterial administration 
of the functionalized CNTs, and external laser irradiation. 
All these could be safely achieved in humans by means 
of minimally invasive surgery, with major benefits for the 
patient. Thus, from a surgical point of view, by laparoscopy 
(also known as minimally invasive surgery or videoscopic 
surgery) it is possible to identify the main artery supply of 
the tumor (using intraoperative Doppler ultrasound) and to 
intra-arterially administer CNTs solution followed by laser 
irradiation. Moreover in future mini-laser diodes could be 
developed for proper access in the abdominal cavity through 
laparoscopic trocars. The advantages of such a minimally 
invasive approach are numerous and include: reduced post-
operative pain, reduced hospitalization, quicker return to 
social activities, and, ultimately, improved cosmetics and 
reduced wound complications. As an alternative to laparos-
copy, natural orifice translumenal endoscopic surgery and a 
percutaneous approach under ultrasound/CT guidance may 
also be used for the specific delivery of bionanosystems 
inside tumors.
Conclusion
CNTs provide opportunities for designing and tuning prop-
erties that are not possible with other types of therapeutic 
vectors and have a bright future as a new generation of 
photothermal agents. With the increasing capital of knowl-
edge and the development of technology, we expect rapid 
advancement in the field of thermal ablation of human cancer 
mediated by biofunctionalized CNTs in the years to come. 
Efficient strategies for targeting ligands on CNTs for tumor 
nanophotothermolysis are also expected to further enhance 
treatment efficacy. Nevertheless, further research is required 
for the careful assessment of unexpected toxicities and 
biodistribution in early stage clinical trials.
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multiwalled carbon nanotubes. Int J Nanomedicine. 2011;6(1):915–928.19 Copyright © 2011 Dove Medical Press.
Abbreviations: FITC, fluorescein isothiocyanate; HSA, human serum albumin; MWCNTs, multiwalled carbon nanotubes.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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